Terms: = Ovarian cancer AND SERPINE1, PAI, PAI-1, PAI1, PLANH1 AND Diagnosis
14 results:
1. Characterization of adnexal lesions using photoacoustic imaging to improve sonographic O-RADS risk assessment.
Zhu Q; Luo H; Middleton WD; Itani M; Hagemann IS; Hagemann AR; Hoegger MJ; Thaker PH; Kuroki LM; MCourt CK; Mutch DG; Powell MA; Siegel CL
Ultrasound Obstet Gynecol; 2023 Dec; 62(6):891-903. PubMed ID: 37606287
[TBL] [Abstract] [Full Text] [Related]
2. A Photoacoustic Contrast Nanoagent with a Distinct Spectral Signature for ovarian cancer Management.
St Lorenz A; Moses AS; Mamnoon B; Demessie AA; Park Y; Singh P; Taratula O; Taratula OR
Adv Healthc Mater; 2023 Apr; 12(9):e2202946. PubMed ID: 36495088
[TBL] [Abstract] [Full Text] [Related]
3. Design of Metaheuristic Optimization-Based Vascular Segmentation Techniques for Photoacoustic Images.
Vaiyapuri T; Dutta AK; Sikkandar MY; Gupta D; Alouffi B; Alharbi A; Rauf HT; Kadry S
Contrast Media Mol Imaging; 2022; 2022():4736113. PubMed ID: 35173560
[TBL] [Abstract] [Full Text] [Related]
4. Investigation of hypoxia networks in ovarian cancer via bioinformatics analysis.
Zhang K; Kong X; Feng G; Xiang W; Chen L; Yang F; Cao C; Ding Y; Chen H; Chu M; Wang P; Zhang B
J Ovarian Res; 2018 Feb; 11(1):16. PubMed ID: 29482638
[TBL] [Abstract] [Full Text] [Related]
5. Expression, Intracellular Localization, and Prognostic Value of Plasminogen Activator Inhibitor 1 and pai-1 RNA-Binding Protein 1 in Primary and Recurrent ovarian cancer: A Study of the Tumor Bank ovarian cancer Network.
Koensgen D; Stope MB; Tuerbachova I; Bruennert D; Kohlmann T; Braicu I; Sehouli J; Denkert C; Darb-Esfahani S; Stickeler E; Sofroni D; Dahl E; Mustea A
Gynecol Obstet Invest; 2018; 83(5):508-514. PubMed ID: 28738361
[TBL] [Abstract] [Full Text] [Related]
6. Testing breast cancer serum biomarkers for early detection and prognosis in pre-diagnosis samples.
Kazarian A; Blyuss O; Metodieva G; Gentry-Maharaj A; Ryan A; Kiseleva EM; Prytomanova OM; Jacobs IJ; Widschwendter M; Menon U; Timms JF
Br J Cancer; 2017 Feb; 116(4):501-508. PubMed ID: 28081538
[TBL] [Abstract] [Full Text] [Related]
7. Biomarkers in Breast cancer: Where Are We and Where Are We Going?
Duffy MJ; Walsh S; McDermott EW; Crown J
Adv Clin Chem; 2015; 71():1-23. PubMed ID: 26411409
[TBL] [Abstract] [Full Text] [Related]
8. Expression of urokinase plasminogen activator and plasminogen activator inhibitor type-1 in ovarian cancer and its clinical significance.
Zhang W; Ling D; Tan J; Zhang J; Li L
Oncol Rep; 2013 Feb; 29(2):637-45. PubMed ID: 23174953
[TBL] [Abstract] [Full Text] [Related]
9. Evaluation of biomarker panels for early stage ovarian cancer detection and monitoring for disease recurrence.
Havrilesky LJ; Whitehead CM; Rubatt JM; Cheek RL; Groelke J; He Q; Malinowski DP; Fischer TJ; Berchuck A
Gynecol Oncol; 2008 Sep; 110(3):374-82. PubMed ID: 18584856
[TBL] [Abstract] [Full Text] [Related]
10. Disease processes may be reflected by correlations among tissue kallikrein proteases but not with proteolytic factors uPA and pai-1 in primary ovarian carcinoma.
Dorn J; Harbeck N; Kates R; Magdolen V; Grass L; Soosaipillai A; Schmalfeldt B; Diamandis EP; Schmitt M
Biol Chem; 2006 Aug; 387(8):1121-8. PubMed ID: 16895483
[TBL] [Abstract] [Full Text] [Related]
11. [Conventional and experimental prognostic factors in ovarian cancer].
Sehouli J; Mustea A; Könsgen D; Lichtenegger W
Zentralbl Gynakol; 2004 Oct; 126(5):315-22. PubMed ID: 15478050
[TBL] [Abstract] [Full Text] [Related]
12. Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis and therapy.
Santin AD; Zhan F; Bellone S; Palmieri M; Cane S; Bignotti E; Anfossi S; Gokden M; Dunn D; Roman JJ; O'Brien TJ; Tian E; Cannon MJ; Shaughnessy J; Pecorelli S
Int J Cancer; 2004 Oct; 112(1):14-25. PubMed ID: 15305371
[TBL] [Abstract] [Full Text] [Related]
13. Discrimination between uterine serous papillary carcinomas and ovarian serous papillary tumours by gene expression profiling.
Santin AD; Zhan F; Bellone S; Palmieri M; Cane S; Gokden M; Roman JJ; O'Brien TJ; Tian E; Cannon MJ; Shaughnessy J; Pecorelli S
Br J Cancer; 2004 May; 90(9):1814-24. PubMed ID: 15208622
[TBL] [Abstract] [Full Text] [Related]
14. Analysis of potential prognostic factors in 111 patients with ovarian cancer.
Hornung R; Urs E; Serenella E; Edward W; Ursula S; Urs H; Daniel F
Cancer Lett; 2004 Mar; 206(1):97-106. PubMed ID: 15019165
[TBL] [Abstract] [Full Text] [Related]